— So far this year alone, 25 TULSA-related scientific research presentations have been delivered at major medical meetings around the world — — Of those, eight (8) presentations were from leading ...
About Profound Medical Corp. Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. Profound is ...
To release full third quarter 2025 financial results on November 13th; conference call to followTORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or ...
Weight loss surgery, or bariatric surgery, offers a transformative option, helping patients to lose significant weight when ...
Sara Sidner, who returned to work following breast reconstruction surgery, is opening up about the emotional toll.
— Clinical evidence continues to highlight TULSA’s ability to treat an unrivalled variety of patients with localized prostate cancer and/or BPH — “The various presentations made at AUA and other major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results